InvestorsHub Logo
Followers 2
Posts 307
Boards Moderated 0
Alias Born 09/22/2006

Re: None

Wednesday, 04/22/2020 10:42:27 AM

Wednesday, April 22, 2020 10:42:27 AM

Post# of 34625
Any thoughts on Seattle Genetics..FDA approval of HER2 + breast cancer drug Tukysa? Did they come first and left TPIV clinical studies "in the dust?"
Secondly, were we expecting updates in April?
Thirdly, what do we know of any advances in the last six + months? A lack of communication usually does not bode well for what ever successes may be.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News